Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRBP

Corbus Pharmaceuticals Holdings Inc

May 22 • 04:00PM ET

11.35

-0.16 -1.39 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: NVCT MGNX IPSC PGEN KPTI

| Held by: VTI VXF DFAS IWC AVSC DFMC OZEM DFAC DFAU DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.81	Insider Own	10.53%	Shs Outstand	17.74M	Perf Week	2.90%
Market Cap	210.29M	Forward P/E	-	EPS next Y	-5.18	Insider Trans	-3.04%	Shs Float	16.58M	Perf Month	11.06%
Enterprise Value	72.90M	PEG	-	EPS next Q	-1.26	Inst Own	61.00%	Short Float	8.49%	Perf Quarter	52.96%
Income	-84.53M	P/S	-	EPS this Y	21.40%	Inst Trans	-1.42%	Short Ratio	5.34	Perf Half Y	-3.98%
Sales	0.00M	P/B	1.59	EPS next Y	-11.71%	ROA	-59.44%	Short Interest	1.41M	Perf YTD	39.43%
Book/sh	7.12	P/C	1.52	EPS next 5Y	1.60%	ROE	-66.70%	52W High	20.56 -44.80%	Perf Year	50.53%
Cash/sh	7.48	P/FCF	-	EPS past 3/5Y	16.56% 32.70%	ROIC	-66.90%	52W Low	6.72 68.90%	Perf 3Y	2.16%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	12.45% 8.47%	Perf 5Y	-78.63%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-37.60%	Oper. Margin	-	ATR (14)	0.92	Perf 10Y	-86.04%
Dividend Ex-Date	-	Quick Ratio	7.92	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	56.69	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.92	EPS Q/Q	11.75%	SMA20	6.49%	Beta	2.70	Target Price	41.22
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	13.11%	Rel Volume	2.11	Prev Close	11.51
Employees	36	LT Debt/Eq	0.00	Earnings	May 12 BMO	SMA200	9.39%	Avg Volume	263.86K	Price	11.35
IPO	Oct 27, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.78% -	Trades		Volume	556,350	Change	-1.39%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)